KGK Science Leads the Nutraceutical Industry into a New Era of Scientific and Statistical Concepts
A significant shift has taken place in scientific and statistical concepts in the nutraceutical space – a shift that Dr. Mal Evans, Chief Scientific Officer, KGK Science, and her team has been advocating for since 2014.
KGK Science Grows with the Addition of Dr. Corey Hilmas as Chief Regulatory Officer
Dr. Corey Hilmas brings substantial experience and industry credentials to KGK, allowing them to expand and bolster their regulatory services.
KGK Science Secures Cannabis Research License for a Clinical Trial Sponsored by New Age Nanotech
KGK Science Inc. has been issued a Cannabis Research License by Health Canada, Controlled Substances and Cannabis Branch, allowing the company to possess and administer cannabis for a Phase I human clinical trial.
KGK Science Applauds the Efforts of Congress to Begin Removing Regulatory Hurdles for CBD
KGK Science Welcomes This Bipartisan Amendment from the House. The Amendment Reflects Both the Intent and Spirit of the Dietary Supplement Health and Education Act of 1994, Which Gave Authority Over Supplements and Struck a Critical Balance Between...
KGK Science Joins the Natural Products Association as a New Board Member
The Time is Right for Us to Be a Leader at the Table in Those Board Discussions
KGK Science Inc. Announces Appointment of Stephen Holmes to CFO/COO and Ashley ten Haaf to...
London, Ontario, September 10, 2018 – Najla Guthrie, President & CEO, of KGK Science Inc. (
KGK Science Inc. Announces Appointment of Mal Evans Ph.D to Chief Scientific Officer
London, Ontario, August 20, 2018 – Najla Guthrie, President & CEO, of KGK Science Inc. (
ChromaDex Clinical Trial Studying NIAGENÂ® Well Underway, With Eight Additional Collaborative Human
IRVINE, Calif., July 20, 2016 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions for dietary supplement, food ...
KGK Synergize Inc. To Run Half Marathon In Support Of Vitamin Angels
LONDON, ON, NOVEMBER 14, 2013 – KGK Synergize Inc., a contract research organization offering human clinical trials to the health nutrition industry, will be participating in the Rock ‘n’ Roll Las Vegas...
Next Pharmaceuticals Acquires Sytrinol
SALINAS, Calif., June 4, 2013—Next Pharmaceuticals acquired the distribution rights, patents, trademarks and scientific knowledge for Sytrinol from KGK Synergize....
KGK Synergize Inc. Welcomes Angela Kelly To Our Team!
LONDON, ON, FEBRUARY 1, 2013 – KGK Synergize Inc., a contract research organization offering human clinical trials to the health nutrition industry, is very pleased to welcome Angela Kelly to the KGK Synergize Inc....
KGK Synergize Inc. Announces Settlement Of Its Lawsuit With Sourceone Global Partners, Inc.
LONDON, ON, January 27, 2012– KGK Synergize Inc. (“KGK”), a product development and contract research organization for the health nutrition industry, announced today the settlement of the lawsuit agains...